Skip to main navigation

About

Who We Are

Management Team
Board of Directors
Program Partners

Pipeline

Cardiovascular
Oncology
Ophthalmology
Inflammatory Disease

Patients

A Message to Our Patients
Our Areas of Focus
Clinical Trials

Investors

News & Events

News Releases
Events
Presentations

Stock

Stock Quote & Chart
Analyst Coverage

Governance

Documents & Charters
Management Team
Board of Directors
Committee Composition
Board Diversity Matrix

Financials

SEC Filings

IR Resources

Investor FAQs
Email Alerts
Contact IR

Contact

English
Chinese, Simplified

News Releases

Year

February 28, 2024

LianBio Announces Voluntarily Delisting from Nasdaq

February 13, 2024

LianBio Announces Completion of Strategic Review

Print Page

Email Alerts

RSS Feeds

Contact IR

Connect with us on social media.

About

Who We Are Management Team Board of Directors Program Partners

Pipeline Cardiovascular Oncology Ophthalmology Inflammatory Disease

Patients A Message to Our Patients Our Areas of Focus Clinical Trials

Investors News & Events Stock Governance Financials IR Resources

Contact

© 2024 LianBio. All Rights Reserved.